Executive record
Christopher Fenimore
Christopher Fenimore signed Regeneron Pharmaceuticals's latest annual report, the 10-K filed February 4, 2026, as Executive Vice President, Finance and Chief Financial Officer (Principal Financial Officer).
1 verified record · 1 company · current seat on the record: Regeneron Pharmaceuticals
Career line from the records
1Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-02-0410-K signatureRegeneron Pharmaceuticalscurrent seat
Signed the annual report as Executive Vice President, Finance and Chief Financial Officer (Principal Financial Officer)
10-K filed February 4, 2026 · sec.gov
Companies
1This page lists only verified filing records that name Christopher Fenimore, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.